Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10738350rdf:typepubmed:Citationlld:pubmed
pubmed-article:10738350lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:10738350lifeskim:mentionsumls-concept:C0543467lld:lifeskim
pubmed-article:10738350lifeskim:mentionsumls-concept:C0162577lld:lifeskim
pubmed-article:10738350pubmed:issue4lld:pubmed
pubmed-article:10738350pubmed:dateCreated2000-4-25lld:pubmed
pubmed-article:10738350pubmed:abstractTextThe medium term (4-year post randomization) results from CABRI indicate that the principal difference between those randomized to coronary angioplasty and those to coronary surgery has been the much greater need for repeat revascularization in the former. A number of factors may play a role in the greater repeat revascularization rate post coronary angioplasty, these include coronary restenosis, residual coronary artery disease, coronary artery disease progression. In the longer term, graft failure in those who have undergone coronary surgery will be important, and it remains to be seen what the effect of this will be.lld:pubmed
pubmed-article:10738350pubmed:languageenglld:pubmed
pubmed-article:10738350pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10738350pubmed:citationSubsetIMlld:pubmed
pubmed-article:10738350pubmed:statusMEDLINElld:pubmed
pubmed-article:10738350pubmed:monthDeclld:pubmed
pubmed-article:10738350pubmed:issn1084-2764lld:pubmed
pubmed-article:10738350pubmed:authorpubmed-author:RickardsA FAFlld:pubmed
pubmed-article:10738350pubmed:authorpubmed-author:BowkerT JTJlld:pubmed
pubmed-article:10738350pubmed:authorpubmed-author:KurbaanA SASlld:pubmed
pubmed-article:10738350pubmed:copyrightInfoCopyright 1999 Harcourt Publishers Ltd.lld:pubmed
pubmed-article:10738350pubmed:issnTypePrintlld:pubmed
pubmed-article:10738350pubmed:volume4lld:pubmed
pubmed-article:10738350pubmed:ownerNLMlld:pubmed
pubmed-article:10738350pubmed:authorsCompleteYlld:pubmed
pubmed-article:10738350pubmed:pagination179-84lld:pubmed
pubmed-article:10738350pubmed:dateRevised2010-11-18lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:meshHeadingpubmed-meshheading:10738350...lld:pubmed
pubmed-article:10738350pubmed:year1999lld:pubmed
pubmed-article:10738350pubmed:articleTitleTrials of angioplasty and surgery: CABRI.lld:pubmed
pubmed-article:10738350pubmed:affiliationDepartment of Cardiology, Imperial College School of Medicine at St Mary's Hospital, Praed Street, London, W2 1NY, UK.lld:pubmed
pubmed-article:10738350pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10738350pubmed:publicationTypeClinical Triallld:pubmed
pubmed-article:10738350pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:10738350pubmed:publicationTypeControlled Clinical Triallld:pubmed
pubmed-article:10738350pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed